Comparison of image-derived and arterial input functions for estimating the rate of glucose metabolism in therapy-monitoring 18F-FDG PET studies
L. de Geus-Oei, E. Visser, P. Krabbe, B. van Hoorn, E. Koenders, A. Willemsen, J. Pruim, F. Corstens and W. OyenArticles
JNM
2006
945--949
Improved tumour detection by gastrin receptor scintigraphy in patients with metastasised medullary thyroid carcinoma
M. Gotthardt, M. Béhé, D. Beuter, A. Battmann, A. Bauhofer, T. Schurrat, M. Schipper, H. Pollum, W. Oyen and T. BehrArticles
EJNMMI
2006
1273--1279
Added value of gastrin receptor scintigraphy in comparison to somatostatin receptor scintigraphy in patients with carcinoids and other neuroendocrine tumours
M. Gotthardt, M. Béhé, J. Grass, A. Bauhofer, A. Rinke, M. Schipper, M. Kalinowski, R. Arnold, W. Oyen and T. BehrArticles
Endocr Relat Cancer
2006
1203--1211
Nuclear medicine imaging and therapy of neuroendocrine tumours
M. Gotthardt, I. Dijkgraaf, O. Boerman and W. OyenArticles
CANI
2006
S178--S184
A new technique for in vivo imaging of specific GLP-1 binding sites: first results in small rodents
M. Gotthardt, G. Lalyko, J. van Eerd-Vismale, B. Keil, T. Schurrat, M. Hower, P. Laverman, T. Behr, O. Boerman, B. Göke and M. BéhéArticles
REGPEP
2006
162--167
What is the best pre-therapeutic dosimetry for successful radioiodine therapy of multifocal autonomy?
M. Gotthardt, C. Rubner, A. Bauhofer, F. Berce, W. Oyen, J. Goecke, A. Pfestroff, A. Schlieck, F. Corstens, M. Béhé and T. BehrArticles
Nuklearmedizin
2006
206--212
How to successfully implement E-learning for both students and teachers
M. Gotthardt, M. Siegert, A. Schlieck, S. Schneider, A. Kohnert, M. Gross, C. Schäfer, R. Wagner, S. Hörmann, T. Behr, R. Engenhart-Cabillic, K. Klose, H. Jungclas and U. GlowallaArticles
AR
2006
379--390
Decrease of (99m)Tc-uptake in autonomous thyroid tissue in Germany since the 1970s. Clinical implications for radioiodine therapy
M. Gotthardt, M. Stübinger, J. Pansegrau, B. Buchwald, J. Goecke, A. Pfestroff, F. Corstens and T. BehrArticles
Nuklearmedizin
2006
122--125
Caffeine prevents protection in two human models of ischemic preconditioning
N. Riksen, Z. Zhou, W. Oyen, R. Jaspers, B. Ramakers, R. Brouwer, O. Boerman, N. Steinmetz, P. Smits and G. RongenArticles
JACC
2006
700--707
Level of fluorodeoxyglucose uptake predicts risk for recurrence in melanoma patients presenting with lymph node metastases
E. Bastiaannet, O. Hoekstra, W. Oyen, P. Jager, T. Wobbes and H. HoekstraArticles
AOSO
2006
919--926
Impact of [18F]fluorodeoxyglucose positron emission tomography on surgical management of melanoma patients
E. Bastiaannet, W. Oyen, S. Meijer, O. Hoekstra, T. Wobbes, P. Jager and H. HoekstraArticles
BJS
2006
243--249
In vivo release of rhBMP-2 loaded porous calcium phosphate cement pretreated with albumin
P. Ruhé, O. Boerman, F. Russel, A. Mikos, P. Spauwen and J. JansenArticles
JMATSCIMATMED
2006
919--927
Functionalization of multilayered DNA-coatings with bone morphogenetic protein 2
J. van den Beucken, X. Walboomers, O. Boerman, M. Vos, N. Sommerdijk, T. Hayakawa, T. Fukushima, Y. Okahata, R. Nolte and J. JansenArticles
JCONREL
2006
63--72
Targeting of biliary cancer with radiolabeled chimeric monoclonal antibody CG250
B. Hendrickx, C. Punt, O. Boerman, E. Postema, E. Oosterwijk, A. Mavridu, F. Corstens and W. OyenArticles
CANBR
2006
263--268
Thrombogenicity and related biological properties of heparin bonded collagen coated polyester and human umbilical vein prosthetic vascular grafts
D. Scharn, W. Oyen, P. Klemm, A. Verhofstad and J. van der VlietArticles
JSURRES
2006
182--189
From anatomical to biological target volumes: the role of PET in radiation treatment planning
D. Schinagl, J. Kaanders and W. OyenArticles
CANI
2006
S107--S116
Transforming growth factor-beta1 release from a porous electrostatic spray deposition-derived calcium phosphate coating
M. Siebers, X. Walboomers, S. Leewenburgh, J. Wolke, O. Boerman and J. JansenArticles
TISENG
2006
2449--2456
Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity
M. den Brok, R. Sutmuller, S. Nierkens, E. Bennink, C. Frielink, L. Toonen, O. Boerman, C. Figdor, T. Ruers and G. AdemaArticles
BJC
2006
896--905
In vivo molecular prediction of carbonic anhydrase IX-G250MN expression on immunotherapy outcome in renal cancer
A. Brouwers, O. Boerman and W. OyenArticles
CLINCR
2005
8886; author reply 8886
Radioimmunotherapy with [131I]cG250 in patients with metastasized renal cell cancer: dosimetric analysis and immunologic response
A. Brouwers, W. Buijs, P. Mulders, P. de Mulder, W. van den Broek, C. Mala, E. Oosterwijk, O. Boerman, F. Corstens and W. OyenArticles
CLINCR
2005
7178s--7186s